Funding for in-home COVID vaccine assessments ‘inadequate’ GPs have questioned the lack of a dedicated MBS item number for housebound patients.
Blood clot case under investigation following Pfizer vaccine The news comes as Australia moves to establish local mRNA manufacturing capacity and experts call for current Pfizer supplies to be redirected to younger cohorts.
What would it take for Australia to manufacture mRNA vaccines? Experts say investing in RNA technology now will help to protect Australia, and its neighbours, beyond the current pandemic.
ATAGI issues GPs with guidance for clotting condition ‘likely’ linked to COVID vaccine The national advisory body is urging vaccine providers to be aware of post-vaccination warning signs, including new onset of severe persistent headache that is not settling with analgesia.
Calls for global strategy of ‘maximum suppression’ of COVID-19 New variants ‘have changed the game’ and vaccines alone will not be enough, according to a group of international experts.
More advice on vaccines for immunocompromised patients The new guidance provides more detail for GPs involved in the rollout, including information around the timing of vaccinations.
GPs need ‘complete predictability on supply’: Calls for better communication amid vaccine delays Lagging deliveries have forced some GPs to be creative in securing vaccines for their patients.
Ongoing confusion over COVID vaccine billing But the Federal Government’s stance is clear – patients should not be charged for vaccine-related consultations.
ATAGI advice eases COVID vaccination uncertainty ahead of rollout The latest guidance from the national vaccine advisory group covers storage and preparation requirements for the Oxford University/AstraZeneca multidose vials.
‘There’s a lot of vaccine hesitancy out there’ Aboriginal and Torres Strait Islander health experts speak to newsGP about steps to address misinformation and hesitancy ahead of phase 1b.